TCT-218 Balancing The Risk Between Myocardial Infarction and Clinically Significant Bleeding With Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation

Drug Eluting Stent ◽

Drug Eluting ◽

Clinically Significant

Comparison of Three-Year Clinical Outcomes with Nonextended Versus Extended Dual Antiplatelet Therapy Between First- and Second-Generation Drug-Eluting Stent Implantation in Patients with Acute Myocardial Infarction: Data from the Infarct Prognosis Study

Journal of Interventional Cardiology ◽

10.1111/j.1540-8183.2012.00719.x ◽

2012 ◽

Vol 25 (3) ◽

pp. 245-252

Author(s):

KI-WOON KANG ◽

BYEONG-KEUK KIM ◽

JI-YONG JANG ◽

HYE SUN LEE ◽

JUNG-SUN KIM ◽

...

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Clinical Outcomes ◽

Antiplatelet Therapy ◽

Stent Implantation ◽

Second Generation ◽

Drug Eluting Stent ◽

Drug Eluting ◽

First And Second Generation

A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the “DAPT-STEMI trial”

American Heart Journal ◽

10.1016/j.ahj.2017.02.018 ◽

2017 ◽

Vol 188 ◽

pp. 11-17 ◽

Cited By ~ 11

Author(s):

Elvin Kedhi ◽

Enrico Fabris ◽

Martin van der Ent ◽

Mark W. Kennedy ◽

Pawel Buszman ◽

...

Keyword(s):

Myocardial Infarction ◽

Antiplatelet Therapy ◽

Stent Implantation ◽

St Elevation Myocardial Infarction ◽

Drug Eluting Stent ◽

Open Label ◽

Drug Eluting ◽

St Elevation ◽

Open Label Trial

Management of peridural catheter removal during dual antiplatelet therapy after postoperative myocardial infarction and drug-eluting stent implantation, applying the "bridging therapy" concept

Minerva Anestesiologica ◽

10.23736/s0375-9393.18.12906-3 ◽

2018 ◽

Vol 84 (10) ◽

Author(s):

Tindaro Mogavero ◽

Rocco Pace ◽

Luigi Vetrugno

Keyword(s):

Myocardial Infarction ◽

Antiplatelet Therapy ◽

Stent Implantation ◽

Catheter Removal ◽

Drug Eluting Stent ◽

Bridging Therapy ◽

Postoperative Myocardial Infarction ◽

Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials

The Lancet ◽

10.1016/s0140-6736(15)60263-x ◽

2015 ◽

Vol 385 (9985) ◽

pp. 2371-2382 ◽

Cited By ~ 232

Author(s):

Tullio Palmerini ◽

Umberto Benedetto ◽

Letizia Bacchi-Reggiani ◽

Diego Della Riva ◽

Giuseppe Biondi-Zoccai ◽

...

Keyword(s):

Bayesian Network ◽

Antiplatelet Therapy ◽

Stent Implantation ◽

Meta Analysis ◽

Drug Eluting Stent ◽

Randomised Trials ◽

Drug Eluting ◽

Extended Duration

Addition of Cilostazol to Conventional Dual Antiplatelet Therapy Reduces the Risk of Cardiac Events and Restenosis After Drug-Eluting Stent Implantation: A Meta-Analysis

The Journal of Clinical Pharmacology ◽

10.1002/jcph.64 ◽

2013 ◽

Vol 53 (5) ◽

pp. 532-539 ◽

Cited By ~ 4

Author(s):

Zhangwei Chen ◽

Juying Qian ◽

Yinghua Chen ◽

Jianying Ma ◽

Junbo Ge

Keyword(s):

Antiplatelet Therapy ◽

Stent Implantation ◽

Meta Analysis ◽

Drug Eluting Stent ◽

Cardiac Events ◽

Optimal Duration of Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation: A Pairwise and Network Meta-Analysis of Randomised Controlled Trials

Clinical Therapeutics ◽

10.1016/j.clinthera.2017.05.152 ◽

2017 ◽

Vol 39 (8) ◽

pp. e49

Author(s):

Y. Fei ◽

M.F. Tsoi ◽

T.T. Cheung ◽

B.M.Y. Cheung

Keyword(s):

Antiplatelet Therapy ◽

Stent Implantation ◽

Randomised Controlled Trials ◽

Meta Analysis ◽

Drug Eluting Stent ◽

Controlled Trials ◽

Optimal Duration ◽

Drug Eluting ◽

Randomised Controlled

Effects of Cilostazol-Based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy After Coronary Drug-Eluting Stent Implantation: An Updated Meta-Analysis of the Randomized Controlled Trials

Clinical Drug Investigation ◽

10.1007/s40261-018-0711-8 ◽

2018 ◽

Vol 39 (1) ◽

pp. 1-13 ◽

Cited By ~ 3

Author(s):

Shijie Zhao ◽

Zhaoshuang Zhong ◽

Guoxian Qi ◽

Liye Shi ◽

Wen Tian

Keyword(s):

Randomized Controlled Trials ◽

Antiplatelet Therapy ◽

Stent Implantation ◽

Meta Analysis ◽

Drug Eluting Stent ◽

Controlled Trials ◽

Randomized Controlled ◽

Triple Antiplatelet Therapy ◽

Will We Ever Know the Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation?⁎⁎Editorials published in JACC: Cardiovascular Interventions reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Interventions or the American College of Cardiology.

JACC Cardiovascular Interventions ◽

10.1016/j.jcin.2011.08.003 ◽

2011 ◽

Vol 4 (10) ◽

pp. 1129-1132 ◽

Cited By ~ 14

Author(s):

Adnan Kastrati ◽

Robert A. Byrne ◽

Stefanie Schulz

Keyword(s):

Antiplatelet Therapy ◽

Stent Implantation ◽

Drug Eluting Stent ◽

Optimal Duration ◽

Drug Eluting ◽

Cardiovascular Interventions

The Use of Single Versus Dual Antiplatelet Therapy Beyond 1 Year Following Drug-Eluting Stent Implantation

Current Cardiology Reports ◽

10.1007/s11886-010-0128-3 ◽

2010 ◽

Vol 12 (5) ◽

pp. 357-360

Author(s):

Matthew E. Wiisanen ◽

David J. Moliterno

Keyword(s):

Antiplatelet Therapy ◽

Stent Implantation ◽

Drug Eluting Stent ◽

Drug Eluting ◽

Single Versus

Second-Generation Drug-Eluting Stent Implantation Followed by 6- Versus 12-Month Dual Antiplatelet Therapy

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2014.09.008 ◽

2014 ◽

Vol 64 (20) ◽

pp. 2086-2097 ◽

Cited By ~ 278

Author(s):

Antonio Colombo ◽

Alaide Chieffo ◽

Arian Frasheri ◽

Roberto Garbo ◽

Monica Masotti-Centol ◽

...

Keyword(s):

Antiplatelet Therapy ◽

Stent Implantation ◽

Second Generation ◽

Drug Eluting Stent ◽